Longbio Pharma
Clinical trials sponsored by Longbio Pharma, explained in plain language.
-
Researchers track Long-Term effects of blood disorder treatment
Disease control Not yet recruitingThis study continues to test an investigational injection called LP-005 in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. It follows patients who completed an earlier trial to monitor the treatment's long-term safety and how well it controls the dis…
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Apr 02, 2026 02:12 UTC
-
New drug trial aims to protect kidneys from immune system attack
Disease control Not yet recruitingThis study is testing an investigational drug called LP-005 for people with kidney diseases caused by an overactive part of the immune system called the complement system. The drug is given as an injection in addition to standard treatment. Researchers will measure if it reduces …
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New injection tested for stubborn sinus polyps
Disease control Not yet recruitingThis study is testing an investigational injection called LP-003 for people with chronic sinusitis and nasal polyps that haven't responded well to standard treatments. About 150 participants will be randomly assigned to receive either the real injection or a placebo (dummy treatm…
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC